Published: 2022-01-28

Indications, contraindications, and clinical significance of Holter monitoring device

Marwah Yakoop Abdullah, Traad L. Zarei, Mubarak M. Althaidy, Ibrahim A. Alghamdi, Abdulrhman S. Alkindy, Ibrahim H. Almalki, Jomannah F. Barnawi, Eman H. Alfayez, Amjad S. Alali, Saleh F. Merza, Fatema S. Hasan, Saad K. Almaghrabi


Holter electrocardiogram monitoring devices are mainly indicated to assess the 24-hour heart rate and rhythm, enabling clinicians and physicians to evaluate the underlying disorders, possibly arrhythmias. The clinical significance of these modalities was apparent in different clinical events, including cardiac and non-cardiac ones. Many applications and clinical advantages were reported since the device was first reported, which changed the way how healthcare settings deal with and monitor cardiac rhythm and associated abnormalities. Evidence shows that Holter monitoring devices are useful in the appropriate patient populace and are very efficacious in diagnosing and following cardiac arrhythmias and other different cardiac conditions, which can significantly enhance the prognosis and management of cardiovascular patients. In this context, it has been shown that primary healthcare physicians should always be aware that many patients might be present with asymptomatic cardiac arrhythmias. However, not many studies have adequately assessed them in the non-cardiac population, which calls for conducting more future investigations. In the present literature review study, we aim to discuss the indications, contraindications, and clinical significance of using the Holter monitoring device based on data from the relevant studies in the literature.


Management, Cardiac, Mobile electrocardiogram, Holter, Cardiac diseases, Interventional cardiology

Full Text:



Holter NJ, Generelli JA. Remote recording of physiological data by radio. Rocky Mountain Med J. 1949;46(9):747-51.

De Maria B, Dalla Vecchia LA, Porta A, La Rovere MT. Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation. Herzschrittmachertherapie + Elektrophysiologie. 2021;32(3):315-9.

Pevnick JM, Birkeland K, Zimmer R, Elad Y, Kedan I. Wearable technology for cardiology: An update and framework for the future. Trends in Cardiovasc Med. 2018;28(2):144-50.

Gibson CM, Ciaglo LN, Southard MC, Takao S, Harrigan C, Lewis J, Filopei J, Lew M, Murphy SA, Buros J. Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review. J Thromb Thrombolysis. 2007;23(2):135-45.

Son PT, Reda A, Viet DC, Quynh NXT, Hung DT, Tung TH, Huy NT. Exchange transfusion in the management of critical pertussis in young infants: a case series. Vox Sang. 2021;116(9):976-82.

Pham TS, Reda A, Ngan Nguyen TT, Ng SJ, Huan VT, Viet DC, Huy NT. Blood exchange transfusion in viral hepatitis in a small infant: a case report. Transfus Apher Sci. 2020;59(6):102907.

Galli A, Ambrosini F, Lombardi F. Holter Monitoring and Loop Recorders: From Research to Clinical Practice. Arrhythmia & electrophysiology review. 2016;5(2):136-43.

Giada F, Bartoletti A. Value of Ambulatory Electrocardiographic Monitoring in Syncope. Cardiol Clin. 2015;33(3):361-6.

Wimmer NJ, Scirica BM, Stone PH. The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review. Progress in Cardiovasc Dis. 2013;56(2):195-202.

Nguyen TM, Huan VT, Reda A. Clinical features and outcomes of neonatal dengue at the Children's Hospital 1, Ho Chi Minh, Vietnam. J Clin Virol. 2021;138:104758.

Thieu H, Bach Dat B, Nam NH, Reda A, Duc NT, Alshareef A, Nguyen JG, Ngoc NM, Tien Huy N. Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors. Minerva Med. 2020;111(5):498-501.

Diemberger I, Gardini B, Martignani C, Ziacchi M, Corzani A, Biffi M, Boriani G. Holter ECG for pacemaker/defibrillator carriers: what is its role in the era of remote monitoring? Heart. 2015;101(16):1272-8.

Wang R, Blackburn G, Desai M, et al. Accuracy of Wrist-Worn Heart Rate Monitors. JAMA Cardiol. 2017;2(1):104-6.

El-Qushayri AE, Dahy A, Reda A, Mahmoud MA, Mageed SA, Kamel AMA, Ghozy S. A closer look at the high burden of psychiatric disorders among healthcare workers in Egypt during the COVID-19 pandemic. Epidemiol Health. 2021;43:e2021045.

El-Qushayri AE, Ghozy S, Reda A, Kamel AMA, Abbas AS, Dmytriw AA. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis. Rev Med Virol. 2021;e2278.

Albers GW, Bernstein RA, Brachmann J. Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc. 2016;5(3):e002944.

Dibas M, Doheim MF, Ghozy S, Ros MH, El-Helw GO, Reda A. Incidence and survival rates and trends of skull Base chondrosarcoma: A Population-Based study. Clin Neurol Neurosurg. 2020;198:106153.

Kleiger RE, Miller JP, Bigger JT, Jr., Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256-62.

Mäkikallio TH, Høiber S, Køber L, Torp-Pedersen C, Peng CK, Goldberger AL, Huikuri HV. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. TRACE Investigators. TRAndolapril Cardiac Evaluation. Am J Cardiol. 1999;83(6):836-9.

Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005;26(8):762-9.

Galinier M, Pathak A, Fourcade J. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J. 2000;21(6):475-82.

Nolan J, Batin PD, Andrews R. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998;98(15):1510-6.

La Rovere MT, Pinna GD, Maestri R, Barlera S, Bernardinangeli M, Veniani M, Nicolosi GL, Marchioli R, Tavazzi L; GISSI-HF Investigators. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial. Eur J Heart Fail. 2012;14(12):1410-9.

Guzzetti S, Dassi S, Pecis M, Casati R, Masu AM, Longoni P, Tinelli M, Cerutti S, Pagani M, Malliani A. Altered pattern of circadian neural control of heart period in mild hypertension. J Hypertens. 1991;9(9):831-8.

Bosone D, Fogari R, Ramusino MC, Ghiotto N, Guaschino E, Zoppi A, D'Angelo A, Costa A. Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients. Heart Vessels. 2017;32(5):507-13.

Roche F, Pichot V, Sforza E, Court-Fortune I, Duverney D, Costes F, Garet M, Barthélémy JC. Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis. Eur Respir J. 2003;22(6):937-42.

Kiyono K, Hayano J, Kwak S, Watanabe E, Yamamoto Y. Non-gaussianity of low frequency heart rate variability and sympathetic activation: lack of increases in multiple system atrophy and Parkinson disease. Front Physiol. 2012;3:34.

Kim JS, Lee SH, Oh YS, Park JW, An JY, Park SK, Han SR, Lee KS. Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson's Disease. J Mov Disord. 2016;9(2):97-103.

Jain S, Ton TG, Perera S, Zheng Y, Stein PK, Thacker E, Strotmeyer ES, Newman AB, Longstreth WT Jr. Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study. Mov Disord. 2012;27(8):988-95.

Brandes A, Bethge KP. Long term electrocardiography (Holter monitoring). Herzschrittmachertherapie & Elektrophysiologie. 2008;19(3):107-29.

Steinberg JS, Varma N, Cygankiewicz I. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Annals of Noninvasive Electrocardiology. 2017;22(3):e12447.

Biersteker TE, Schalij MJ, Treskes RW. Impact of Mobile Health Devices for the Detection of Atrial Fibrillation: Systematic Review. JMIR mHealth and uHealth. 2021;9(4):e26161.